How to Buy Context Therapeutics Stock
Context Therapeutics Inc
Context Therapeutics Inc. , a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States.
Context Therapeutics stock last closed at $2.59, up 1.97% from the previous day, and has increased 251.42% in one year. It has overperformed other stocks in the Biotechnology industry by 2.91 percentage points. Context Therapeutics stock is currently +428.57% from its 52-week low of $0.49, and -28.45% from its 52-week high of $3.62.
There are currently 91.88M shares of CNTX outstanding. The market capitalization of CNTX is $237.97M. In the last 24 hours, 701,000 CNTX shares were traded.
How to Buy Context Therapeutics Stock
Not sure how to invest in Context Therapeutics stock? Here's how.
- Choose where to buy Context Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you figure out where to buy Context Therapeutics stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Pick your method of payment and add your info.
- Analyze Context Therapeutics stock: The Context Therapeutics ticker symbol is CNTX. Is Context Therapeutics stock a good investment? Should you buy shares of CNTX? How do CNTX's underlying business fundamentals look? Do top analysts think Context Therapeutics is a good buy? Why has CNTX's stock price moved recently? (Hint: Our stock market research tools can help you decide if CNTX is a good stock to buy).
- Execute your CNTX purchase: Decide if you will purchase CNTX shares at the current market price or use a limit order to purchase CNTX stock at a specific price.
- Keep tabs on your CNTX investment: Create a watchlist to track your position in Context Therapeutics stock.
Step 1: Choose where to buy Context Therapeutics stock
You will need an online brokerage account to access the NASDAQ market and buy CNTX shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal details so you are able to buy CNTX stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start a new trading account.
- Submit your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on our top ranked stock market app, you can securely and quickly fund your account:
Watch the walkthrough below if you need help depositing money into your brokerage account.
Step 4: Analyze Context Therapeutics stock
Once you have decided on the best place to buy Context Therapeutics stock, it's critical to research their stock prior to buying, so you truly understand the risk and upside.
Context Therapeutics quick stats
CNTX Due Diligence Score
WallStreetZen was designed to help average investors perform better fundamental analysis quickly.
You can view all of the due diligence checks on CNTX's stock page.
Is CNTX stock undervalued or overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge CNTX's fair value.
Using relative valuations ratios:
- CNTX may be undervalued based on its P/B ratio of 3.94x, relative to Biotechnology industry P/B ratio of 4.52x
You can do additional valuation research on CNTX's stock here.
CNTX Financial Health Summary
Passed Financial Due Diligence Checks:
- CNTX has a low debt to equity ratio of 0.13.
- There are more short-term assets than short-term liabilities on the CNTX balance sheet.
- Total CNTX debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the CNTX balance sheet.
- CNTX has $66.00M in cash and short term investments. This is sufficient to cover its annual cash burn of $26.42M.
- CNTX has cash burn of 26419328. It has enough cash and short-term investments to cover this for at least one year.
Is it a good time to buy Context Therapeutics stock, according to Wall Street analysts?
Out of 5 Equities analysts who give ratings on CNTX, the consensus analyst rating on Context Therapeutics is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Context Therapeutics stock forecast page.
Metrics for Advanced CNTX Traders
Latest Insiders Trades at CNTX
In the past year, executives and large shareholders at CNTX have bought more shares than they have sold.
Martin A. Lehr, Chief Executive Officer of CNTX, was the latest CNTX insider to buy. They bought $70,100.00 worth of CNTX shares on Jun 9, 2025.
Get more info about who owns CNTX stock here.
Can I get consistent income from CNTX stock?
No, Context Therapeutics doesn't provide an income stream by paying out dividends.
CNTX Social Trading Data
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your CNTX purchase
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount, use a limit order.
Press the Open Trade button and eToro will place the order.
If you need additional info about investing in stocks on eToro, watch the how to video below:
Step 6: Keep tabs on your CNTX investment
Now that you own some CNTX stock, you'll want to keep up with your shares.
Create a watchlist to get notified of important updates regarding your CNTX stock.
CNTX Feed
How to Buy Stock in Context Therapeutics
To summarize, here are the 6 steps for buying Context Therapeutics stock:
- Choose where to buy Context Therapeutics stock
- Open a brokerage account
- Fund your brokerage account
- Analyze Context Therapeutics stock
- Execute your CNTX purchase
- Keep tabs on your CNTX investment
If you require a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to keep an eye on your investment in Context Therapeutics, create a watchlist today.
More Content You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.